ArticleOncology letters2025
Prognostic importance of red blood cell distribution width in patients with glioma: A meta-analysis.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aimed to investigate whether red blood cell distribution width (RDW) was an independent prognosis factor for patients with glioma after surgery. Potential studies were found in four databases including PubMed, Embase, China National Knowledge Infrastructure and the Cochrane Library on 21st July, 2022. To evaluate the prognosis after surgery, hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled to calculate the overall survival (OS) of patients with glioma. Stata V16.0 software was used for data analysis. A total of 8 studies were included, involving 1,468 patients. After collecting and analyzing the data, RDW was demonstrated to be a prognostic factor for OS of patients with glioma (HR=1.51; I
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.